Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rockwell Medical IN (RMTI)

Rockwell Medical IN (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,219
  • Shares Outstanding, K 70,298
  • Annual Sales, $ 61,300 K
  • Annual Income, $ -34,130 K
  • 60-Month Beta 1.30
  • Price/Sales 1.26
  • Price/Cash Flow N/A
  • Price/Book 4.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 +2.94%
on 09/24/20
1.8900 -44.44%
on 09/22/20
-0.2700 (-20.45%)
since 08/28/20
3-Month
1.0200 +2.94%
on 09/24/20
2.1200 -50.47%
on 07/20/20
-0.7400 (-41.34%)
since 06/26/20
52-Week
1.0200 +2.94%
on 09/24/20
3.8500 -72.73%
on 03/06/20
-1.9500 (-65.00%)
since 09/27/19

Most Recent Stories

More News
Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

RMTI : 1.0500 (-1.87%)
Rockwell Medical (RMTI) Soars: Stock Adds 9.7% in Session

Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

QDEL : 198.50 (+0.88%)
RMTI : 1.0500 (-1.87%)
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

AGE : 0.7980 (-5.00%)
OCX : 1.3700 (+4.58%)
RMTI : 1.0500 (-1.87%)
Company News for Sep 11, 2020

Companies in the news are: VRTU, OSTK, KLR, RMTI

RMTI : 1.0500 (-1.87%)
OSTK : 74.68 (+2.48%)
VRTU : 48.65 (+0.31%)
KLR : 7.01 (-4.37%)
Rockwell Medical Enters into Exclusive License Agreement with Jeil Pharmaceutical Co., Ltd., for the Rights to Commercialize Triferic(R) in South Korea

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

RMTI : 1.0500 (-1.87%)
Rockwell Medical to Host Conference Call and Webcast with Management and Key Opinion Leaders to Discuss Potential Novel Indications for Its FPC Platform

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

RMTI : 1.0500 (-1.87%)
Rockwell Medical, Inc. to Present at Upcoming September Investor Conferences

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

RMTI : 1.0500 (-1.87%)
Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 23.08% and 0.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

RMTI : 1.0500 (-1.87%)
Rockwell Medical: 2Q Earnings Snapshot

HACKENSACK, N.J. (AP) _ Rockwell Medical Inc. (RMTI) on Monday reported a loss of $6.9 million in its second quarter.

RMTI : 1.0500 (-1.87%)
Rockwell Medical to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 1.0500 (-1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RMTI with:

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

2nd Resistance Point 1.1500
1st Resistance Point 1.1100
Last Price 1.0500
1st Support Level 1.0300
2nd Support Level 0.9900

See More

52-Week High 3.8500
Fibonacci 61.8% 2.7689
Fibonacci 50% 2.4350
Fibonacci 38.2% 2.1011
Last Price 1.0500
52-Week Low 1.0200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar